Alice Herlihy, MD
Pulmonary Disease · North Chesterfield, VANPI 1902013196
Payments from drug & device makers
Across 298 payments — averaging $61.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- AstraZeneca$1K
- GSK$816
- Sanofi$509
- Genentech USA, Inc.$304
- Grifols USA, LLC$280
- plus $2K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $13,098 |
| AstraZeneca | 32 | $1,059 |
| GSK | 71 | $816 |
| Sanofi | 29 | $509 |
| Genentech USA, Inc. | 17 | $304 |
| Grifols USA, LLC | 12 | $280 |
| Boehringer Ingelheim | 12 | $238 |
| Amgen | 12 | $212 |
| Philips North America LLC | 12 | $187 |
| Paratek Pharmaceuticals, Inc. | 10 | $173 |
| Insmed, Inc. | 10 | $157 |
| Regeneron Healthcare Solutions, Inc. | 8 | $149 |
| Actelion Pharmaceuticals US, Inc. | 7 | $148 |
| Mallinckrodt Hospital Products Inc. | 5 | $127 |
| ANI Pharmaceuticals, Inc. | 4 | $124 |
| Mylan Specialty L.p. | 7 | $114 |
| Inogen, Inc. | 4 | $88 |
| Merck | 3 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Sunovion Pharmaceuticals Inc. | 3 | $56 |
| Vifor Pharma, Inc. | 3 | $56 |
| Pulmonx Corporation | 2 | $51 |
| Novartis | 3 | $48 |
| Covis Pharma GmbH | 2 | $48 |
| Pfizer | 2 | $41 |
| United Therapeutics Corporation | 2 | $38 |
| Baxter Healthcare | 2 | $34 |
| Atricure, Inc. | 1 | $34 |
| 3b Medical, Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Biogen | 1 | $20 |
| Pharming Healthcare, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Sandoz | 1 | $12 |
| Bayer | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
How this compares
$18,471 in reported general payments places this provider in the 80th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in North Chesterfield
- Adam KaiserNorth Chesterfield$67K
- Muhammad AtharNorth Chesterfield$25K
- Steven NathanFalls Church$2.5M
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Vijay SubramaniamWilliamsburg$1.3M
- Rabih HalabiFalls Church$604K
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
- Hannah MannemCharlottesville$326K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.